Results 201 to 210 of about 4,877,471 (249)

Molecular genetics of chronic neutrophilic leukemia, chronic myelomonocytic leukemia and atypical chronic myeloid leukemia [PDF]

, 2014
Bing Li, Robert Peter Gale, Zhijian Xiao
core   +1 more source

Novel lysyl oxidase inhibitors attenuate hallmarks of primary myelofibrosis in mice

International journal of hematology, 2019
O. Leiva, Seng kah Ng, S. Matsuura, V. Chitalia, H. Lucero, A. Findlay, C. Turner, W. Jarolimek, K. Ravid   +8 more
semanticscholar   +1 more source

Valore predittivo di variabili clinico-laboratoristiche in pazienti con mielofibrosi trattati con inibitore di JAK-1/2 [PDF]

, 2011
CARAMAZZA, Domenica
core  

Response: CEBPA promoter hypermethylation in a subset of myeloid/T-lymphoid leukemias with a distinct gene expression profile [PDF]

, 2009
Bas Wouters, Keeshan, Ruud Delwel, Wouters   +3 more
core   +4 more sources

Primary myelofibrosis in rheumatic diseases

Научно-практическая ревматология, 2013
Vladimir Ivanovich Vasilyev, V R Gorodetsky, S Kh Sedyshev, O A Logvinenko, N A Probatova, A I Pavlovskaya, M S Eliseyev, A V Smirnov, G R Fadienko   +8 more
doaj   +1 more source

RUNX1::CBFA2T2 rearranged acute myeloid leukemia transformed from JAK2 V617F mutated primary myelofibrosis. [PDF]

EJHaem
Han L, Koduru P, Cantu M, Fuda F, Chen W.   +4 more
europepmc   +1 more source

MicroRNA Expression Analysis in Patients with Primary Myelofibrosis, Polycythemia vera and Essential Thrombocythemia [PDF]

, 2015
Anıl Tombak, Özlem İzci Ay, Mehmet Emin Erdal, Mehmet Alı Sungur, Mehmet Ali Uçar, Aydan Akdeniz, Eyüp Naci Tiftik   +6 more
openalex   +1 more source

Case report: Primary myelofibrosis presenting with portal hypertension mimicking cirrhosis. [PDF]

Front Med (Lausanne)
Gan X, Yu S, Zhu M, Ning B, He S, Xie X, Tu L, Yu H.   +7 more
europepmc   +1 more source

Safety and efficacy of combined ruxolitinib and decitabine in accelerated and blast-phase myeloproliferative neoplasms [PDF]

, 2018
Abboud, Camille N.
core   +1 more source

Monocytosis is a powerful and independent predictor of inferior survival in primary myelofibrosis

British Journal of Haematology, 2018
A. Tefferi, Sahrish H Shah, M. Mudireddy, T. Lasho, D. Barraco, C. Hanson, R. Ketterling, M. Elliott, M. Patnaik, A. Pardanani, N. Gangat   +10 more
semanticscholar   +1 more source